These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 58810)

  • 21. Clinical pharmacology of the thrombolytic enzyme preparation brinase.
    Frisch EP
    Semin Thromb Hemost; 1989 Jul; 15(3):341-6. PubMed ID: 2688105
    [No Abstract]   [Full Text] [Related]  

  • 22. [Morphology of thrombolysis as affected by a plasmakinase preparation].
    Permiakov NK; Titova GP; Senianskaia NL; Khvatov VB; Platonova TK
    Arkh Patol; 1982; 44(6):31-6. PubMed ID: 6289783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the fibrinolytic effect of ocrase.
    Klöcking HP; Markwardt F; Hentschel H
    Acta Biol Med Ger; 1981; 40(9):1161-6. PubMed ID: 7041495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experimental pulmonary embolism in dogs. Local administration of Aspergillus-oryzae protease I].
    Eie H; Amundsen E
    Nord Med; 1970 Dec; 84(51):1633. PubMed ID: 5490745
    [No Abstract]   [Full Text] [Related]  

  • 25. Combined thrombolytic and Dotter treatment in arterial occlusive disease.
    Eie H; Ro J; Amundsen E; Osvik K
    J Oslo City Hosp; 1972; 22(9):141-8. PubMed ID: 5075930
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fibrinolytic activity of a protease isolated from Aspergillus ochraceus].
    Klöcking HP; Markwardt F
    Acta Biol Med Ger; 1971; 26(1):35-44. PubMed ID: 5103710
    [No Abstract]   [Full Text] [Related]  

  • 27. [Thrombolytic treatment of arterial occlusions with brinase, a proteolytic enzyme produced by aspergillus].
    Numan D; Da Silva MA; Wikner LK; Duckert F
    Schweiz Med Wochenschr; 1974 Dec; 104(50):1865-7. PubMed ID: 4445859
    [No Abstract]   [Full Text] [Related]  

  • 28. [Production and characterization of a soluble ocrase-polyacrylamide preparation (author's transl)].
    Maksimenko AV; Walsmann P
    Pharmazie; 1981; 36(2):117-9. PubMed ID: 7015368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacological and clinical study of the thrombolytic effectiveness of ocrase].
    Klöking K; Vogel H
    Kardiologiia; 1981 Aug; 21(8):36-8. PubMed ID: 7026868
    [No Abstract]   [Full Text] [Related]  

  • 30. [Thrombolytic and pharmacodynamic properties of Aspergillus ochraceus protease].
    Klöcking HP; Markwardt F
    Farmakol Toksikol; 1975; 38(3):341-9. PubMed ID: 1084284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolytic and antithrombotic efficacy of the platelet GPIIb-IIIa antagonist DMP728.
    Mousa SA; Forsythe MS; Diemer M; Bozarth JM; Reilly TM
    Coron Artery Dis; 1994 Nov; 5(11):919-27. PubMed ID: 7719524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental and clinical studies on a protease from Aspergillus oryzae (Brinase): fibrinogen turnover, thrombocyte aggregation and occlusion of the Scribner shunt].
    de Nicola P; Cultrera G; Gibelli A; Manai G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):22-37. PubMed ID: 4134482
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolysis with systemically administered t-PA in a new venous thrombosis model.
    Hayden RE; McLear PW; Phillips JG; Dawson SM
    Laryngoscope; 1989 Jan; 99(1):100-4. PubMed ID: 2491898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lysis of thrombi and emboli by means of streptokinase. I. Activation of fibrinolysis, mechanism of plasmin activity, indications and contra-indications, treatment principles].
    Janda R; Cencora A; Uzieblo W
    Przegl Lek; 1969; 25(10):701-5. PubMed ID: 4242965
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current trends in anticoagulant and thrombolytic therapy of thrombosis].
    Gavrilov OK; Rachinskaia NA; Kaveshnikova BF
    Sov Med; 1975 Sep; (9):53-9. PubMed ID: 781864
    [No Abstract]   [Full Text] [Related]  

  • 36. Thrombolytic treatment with Brinase of dogs with experimental pulmonary embolism.
    Eie H; Amundsen E; Ro JS
    Scand J Thorac Cardiovasc Surg; 1972; 6(2):164-71. PubMed ID: 5046342
    [No Abstract]   [Full Text] [Related]  

  • 37. G4120, an Arg-Gly-Asp containing pentapeptide, enhances arterial eversion graft recanalization with recombinant tissue-type plasminogen activator in dogs.
    Lu HR; Gold HK; Wu Z; Yasuda T; Pauwels P; Rapold HJ; Napier M; Bunting S; Collen D
    Thromb Haemost; 1992 Jun; 67(6):686-91. PubMed ID: 1509410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological potentials for activating the fibrinolytic system].
    Markwardt F
    Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolytic therapy. (Therapeutic fibrinolysis)].
    Haracić M
    Med Arh; 1978; 32(2):89-99. PubMed ID: 713622
    [No Abstract]   [Full Text] [Related]  

  • 40. [Animal experimental studies on a protease from Aspergillus ochraceus].
    Klöcking HP; Hauptmann J; Nowak G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):111-7. PubMed ID: 4134260
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.